The public may require annual vaccines to protect against SARS-CoV-2, Pfizer (NYSE:PFE) CEO Albert Bourla said today.
“It is extremely important to suppress the pool of people that can be susceptible to the virus,” Bourla said in a CNBC interview.
While the details of Pfizer-BioNTech boosters are not yet clear, COVID-19 boosters will likely be based on an mRNA platform.
Get the full story from our sister site, Drug Discovery & Development.